Related Experiment Video
Updated: May 9, 2025

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Cancer-Type-Specific DNA Methylation Is a Source of Vulnerability in Liver Cancer Cells
Karen Minowa1, Miho Seki1, Yui Nagai2
1Division of Biotechnology, Graduate School of Engineering, Maebashi Institute of Technology, Maebashi, Gunma, Japan.
Cancer cells exhibit DNA methylation patterns that create vulnerabilities. Specific gene silencing due to DNA methylation in liver cancer cells, like BCAT2, can be exploited for targeted therapies.
Area of Science:
- Epigenetics
- Cancer Biology
- Genomics
Background:
- DNA methylation is a key epigenetic regulator involved in cancer development.
- Cancer-type-specific DNA methylation can confer differential survival advantages or disadvantages depending on the cellular environment.
Purpose of the Study:
- To investigate cancer-type-specific DNA methylation as a potential vulnerability in cancer cells.
- To identify genes silenced by DNA methylation that impact cancer cell survival and drug response.
Main Methods:
- Bioinformatic profiling of genome-wide DNA methylation across 1165 human cancer cell lines from 25 cancer types.
- Identification of cancer-type-specific methylated genes, with a focus on liver cancer.
- Experimental validation of selected methylation-silenced genes (ASNS, NQO1, FXYD5, BCAT2) in liver cancer cells.
Main Results:
- Significant variation in cancer-type-specific methylated cytosines was observed across organs, with a notable prevalence in blood cancers.
- 73 potential liver cancer-specific methylation-silenced genes were identified.
- Silencing of BCAT2 rendered liver cancer cells vulnerable to BCAT1 inhibition by gabapentin; other identified genes also induced vulnerabilities under specific conditions.
Conclusions:
- Cancer-type-specific DNA methylation can represent a vulnerability exploitable for therapeutic strategies.
- The study provides insights into the biological and clinical relevance of DNA methylation in cancer.
- Findings support the development of novel diagnostic markers and targeted cancer therapies based on epigenetic profiles.
Related Concept Videos
Epigenetic Regulation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Treatment Resistant Cancers
Cell Specific Gene Expression
Cancer Prevention
Some...
Cancers Originate from Somatic Mutations in a Single Cell

